Method for detecting alkaline phosphatase and cardiac troponin I in real time through in-situ fluorescence reaction initiated by copper ions and application
Patent Information
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- NANJING UNIV OF TECH
- Publication Date
- 2021-11-26
Smart Images

Figure 1 
Figure 2 
Figure 3
Abstract
Description
Technical field
[0001] The present invention relates to the construction of the in-situ fluorescent immunoassay sensing platform based on the wavelength of copper ion triggering and its analysis, for real-time sensitive detection CTNI, belonging to the field of nanohosphere sensing. Background technique
[0002] Alkaline phosphatase (ALP) is a membrane binding enzyme, which is widely expressed in liver, bone, intestinal, placenta, kidney. It is mainly responsible for hydrolyzing and transforming monophosphate from various proteins and non-protein substrates. As a recognized biomarker, alkaline phosphatase plays an important role in many important physiological and pathological processes such as cell cycle growth, apoptosis and signal transduction pathways. The normal value of adult serum ALP is generally in 46 ~ 190u / L, children and pregnant women ALP normal value above 500u / l, but serum ALP abnormalities is close to bone disease, liver function disorders, breast cancer, pros...